全球支气管内导管市场规模（按产品、应用、地区、范围和预测）

支气管内管市场规模及预测

2024 年支气管内管市场规模价值为 21.8 亿美元，预计到 2031 年将达到 35.5 亿美元，2024 年至 2031 年的复合年增长率为 6.3%。促进支气管内导管市场成长的主要因素包括由于心血管疾病、呼吸系统疾病、糖尿病、癌症和其他肺部损伤等慢性呼吸系统疾病的日益流行导致手术数量的增加。全球支气管内管市场报告对市场进行了全面的评估。它对关键细分市场、趋势、市场推动因素、阻碍因素、竞争格局以及在市场中发挥关键作用的因素进行了全面的分析。

支气管内导管的全球市场驱动因子

支气管内管市场的市场推动因素可能受到多种因素的影响。

呼吸系统疾病发生率增加

随着气喘、肺癌、慢性阻塞性肺病（COPD）等呼吸系统疾病在世界各地的发生率不断上升，支气管插管在治疗和诊断方面越来越必不可少，越来越受欢迎。

技术开发：

新型涂层的创造、更大的移动性和更好的可视性特征以及支气管内管设计和材料的其他发展正在推动市场的发展。这些发展所带来的患者治疗效果的改善和程序效率的提高促使采用率的提高。

老年人口不断增加：

由于世界人口老化，人们更容易患呼吸系统疾病，对支气管内管的需求日益增加。老年人对治疗呼吸系统疾病的医疗干预需求普遍存在，这推动了市场的扩张。

对微创治疗的需求不断增加：

支气管内管广泛应用于内视镜肺减容术、支气管镜检查等微创手术。随着微创治疗的流行，其具有恢復更快、併发症更少等优势，预计对支气管内管的需求将会飙升。

增加用途：

支气管内导管的用途越来越多地除传统的诊断和治疗目的之外。其在安宁疗护和临终关怀、研究、培训和教育中的应用日益广泛，扩大了市场潜力。

政府资金与措施：

由于政府的资助和改善医疗保健系统以及提高公众对呼吸系统疾病认识的举措，市场正在成长。呼吸照护相关研究和开发计画的资助也促进了支气管插管技术的进步。

增加医疗支出：

医疗保健支出的增加推动了支气管内插管等尖端医疗技术的采用，尤其是在新兴国家。医疗保健基础设施的改善和可支配收入的增加使患者能够获得尖端的诊断和治疗方法，从而推动了市场扩张。

伙伴关係与合作关係：

合作伙伴关係和协作促进了医疗器材製造商、研究中心和医疗机构之间的技术转移，从而加快了产品开发。策略合作伙伴关係使公司能够更有效地解决未满足的医疗需求并提高其市场占有率。

教育与教育活动：

医疗保健和倡导组织正在进行公众意识运动和教育计划，以提高公众对呼吸系统疾病和各种可用治疗方法（包括支气管内插管）的瞭解。人们的认识不断提高，推动了早期诊断和治疗，从而促进了市场的发展。

限制全球支气管内管市场的因素

有几个因素可能会对支气管内管市场造成限製或课题。

气管插管成本高：

在资源匮乏的贫穷国家，支气管插管的费用可能超出了医疗机构的负担能力。此类专业医疗设备的引进可能会因其前期成本过高而受到阻碍，尤其是在资金紧张的地区。

限时兑换规则：

报销规定薄弱阻碍了支气管内手术和相关设备市场的扩张。不同地区和医疗体系的报销率差异可能会影响患者和医护人员对支气管内导管的可负担性和可近性。

复杂的监理环境：

医疗器材审批和商业化的严格规定可能会使新的支气管内管产品难以进入市场。由于必须遵守多个国家不同的监管框架，因此开发和推出产品的过程变得更具课题性且耗时。

技术课题与成果：

支气管内手术技术复杂，容易出现出血、感染、气道损伤等后果。与管道放置、导航和维护有关的技术问题可能会阻碍实施，尤其是对于缺乏经验的医疗保健提供者。

限制熟练员工的取得：

支气管内手术需要专门的训练和知识。由于缺乏合格的肺部疾病专家、介入专家和熟练先进支气管镜技术的呼吸治疗师，支气管内插管和相关程序不太可能被广泛采用。

感染控制问题：

由于支气管内管是可重复使用的医疗设备，因此每次使用后彻底清洁和消毒以防止感染扩散非常重要。有关不良消毒程序和潜在交叉污染的问题可能会危及患者安全并降低对支气管内管产品的信心。

替代疗法：

根据临床情况，药物治疗、肺部復健和手术治疗是支气管内置入的有效替代方案。替代疗法的出现可能会减少对支气管内管的需求，特别是在治疗较不严重的呼吸系统疾病时。

法律与道德问题：

当对高风险患者（例如需要安宁疗护或患有严重肺部疾病的患者）使用支气管内导管时，医疗保健提供者和患者可能会基于道德问题做出决定。市场动态也可能受到不利事件或问题的法律后果的影响。

目录

第 1 章。

市场概况
• 研究范围
• 先决条件

第 2 章执行摘要

第 3 章：经过验证的市场研究方法

• 资料探勘
• 验证
• 主要来源
• 资料来源列表

第 4 章 全球支气管内导管市场展望

• 概述
• 市场动态
  • 驱动程式
  • 阻碍因素
  • 机会
• 波特五力模型
• 价值链分析

第 5 章。

• 概述
• 一次使用/一次性
• 可重复使用

6. 全球支气管内导管市场（依应用）

• 概述
• 医院
• 门诊手术诊所
• 专科诊所

7. 全球支气管内导管市场（按地区）

• 概述
• 北美洲
  • 美国
  • 加拿大
  • 墨西哥
• 欧洲
  • 德国
  • 英国
  • 法国
  • 其他欧洲国家
  亚太地区
  • 中国
  • 日本
  • 印度
  • 其他亚太地区
• 世界其他地区
  • 拉丁美洲
  • 中东和非洲

第 8 章 全球支气管内管市场的竞争格局

• 概述
• 各公司的市场排名
• 主要发展策略

第九章 公司简介

• Sonoma Pharmaceuticals Inc
• Teleflex Incorporated
• Venner Medical GmbH
• Enox Biopharma Inc
• Hospiteknik Healthcare
• Innovative Surface Technologies, Inc
• Bactiguard Holding AB
• C. R. Bard, Inc
• N8 Medical, LLC
• Sharklet Technologies, Inc

第 10 章附录

• 相关研究

Endobronchial Tubes Market Size And Forecast

Endobronchial Tubes Market size was valued at USD 2.18 Billion in 2024 and is projected to reach USD 3.55 Billion by 2031, growing at a CAGR of 6.3% from 2024 to 2031. The major factor that contributes to the growth of the Endobronchial Tubes Market includes an increase in the number of surgical procedures because of the growing popularity of chronic respiratory diseases such as cardiovascular diseases, respiratory diseases, diabetes, cancer, and other lung injuries. The Global Endobronchial Tubes Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.

Global Endobronchial Tubes Market Drivers

The market drivers for the Endobronchial Tubes Market can be influenced by various factors. These may include:

Rising Incidence of Respiratory disorders:

Endobronchial tubes are becoming more and more necessary for both therapeutic and diagnostic purposes as the prevalence of respiratory disorders like asthma, lung cancer, and chronic obstructive pulmonary disease (COPD) climbs globally.

Technological Developments:

The creation of novel coatings, more mobility, and better visibility features, among other developments in endobronchial tube design and materials, are propelling market expansion. The improvements in patient outcomes and procedure efficiency brought about by these developments lead to higher adoption rates.

Growing Aging Population:

The need for endobronchial tubes is being driven by the aging population worldwide, which is more susceptible to respiratory conditions. The need for medical interventions to treat respiratory disorders in the elderly is common, which is driving expansion in the market.

Growing Need for Less Invasive Treatments:

Endobronchial tubes are widely utilized in less invasive treatments including endoscopic lung volume reduction and bronchoscopy. The need for endobronchial tubes is anticipated to soar as a result of a growing inclination towards minimally invasive procedures because of advantages including quicker recovery and a decreased chance of problems.

Increasing Uses:

Endobronchial tubes are being used for purposes other than the conventional diagnostic and therapeutic ones. Their market potential is being expanded by the growing use of them in palliative care and end-of-life interventions, as well as in research, training, and educational contexts.

Government Funding and Initiatives:

The market is growing as a result of government funding and initiatives to upgrade the healthcare system and raise public awareness of respiratory illnesses. Financing for respiratory care-related R&D initiatives encourages endobronchial tube technology advancement as well.

Growing Healthcare Expenditure:

The adoption of cutting-edge medical technologies like endobronchial tubes is aided by rising healthcare spending, especially in emerging nations. Patients may now access cutting-edge diagnostic and therapeutic procedures because to improved healthcare infrastructure and increased disposable incomes, which is propelling market expansion.

Partnerships and Collaborations:

Partnerships and collaborations promote technology transfer and quicken product development amongst medical device producers, research centers, and healthcare institutions. Companies can more efficiently address unmet medical needs and broaden their market presence by forming strategic partnerships.

Initiatives for Public Awareness and Education:

Healthcare organizations and advocacy groups run public awareness campaigns and educational programs to increase public knowledge of respiratory disorders and the range of treatments available, including endobronchial tubes. Growing awareness promotes early diagnosis and treatment, which propels the market.

What's inside a VMR industry report?

Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.

Global Endobronchial Tubes Market Restraints

Several factors can act as restraints or challenges for the Endobronchial Tubes Market. These may include:

Exorbitant Cost of Endobronchial Tubes:

In impoverished nations with little funding, the expense of endobronchial tubes can be unaffordable for medical facilities. Adoption of these specialized medical devices may be hampered by their high initial cost, particularly in environments where financial limitations are an issue.

Limited Reimbursement rules:

The expansion of the endobronchial procedure and related equipment market is hindered by inadequate reimbursement rules. The pricing and accessibility of endobronchial tubes for patients and healthcare professionals may be impacted by variations in reimbursement rates across different areas and healthcare systems.

Complicated Regulatory Environment:

New endobronchial tube products may find it difficult to enter the market because to the strict regulations controlling the approval and commercialization of medical devices. The process of developing and launching a product is made more difficult and time-consuming by the need to comply with various regulatory frameworks in several nations.

Technical Difficulties and consequences:

Endobronchial surgeries are technically complex and have a predisposition to consequences such bleeding, infection, and airway damage. Adoption may be hampered by technical issues with tube installation, navigation, and maintenance, especially for less seasoned medical professionals.

Restricted Access to Skilled Personnel:

Endobronchial surgeries necessitate specialized training and knowledge. Endobronchial tubes and associated operations may not be widely adopted due to a lack of qualified pulmonologists, interventionalists, and respiratory therapists who are experienced in sophisticated bronchoscopic techniques.

Issues with Infection Control:

Because endobronchial tubes are reusable medical equipment, it is important to thoroughly clean and sterilize them in between usage to stop the spread of infection. Issues regarding insufficient sterilization procedures or the potential for cross-contamination could compromise patient safety and diminish confidence in endobronchial tube products.

Alternative Treatment modalities:

In some clinical situations, medication, pulmonary rehabilitation, and surgical therapies are effective substitutes for endobronchial procedures. The need for endobronchial tubes may be curtailed by the availability of substitute therapies, especially for less severe respiratory diseases.

Legal and Ethical Issues:

When using endobronchial tubes in patients who are at risk, such as those who require palliative care or have severe lung illness, medical professionals and patients may make decisions based on ethical concerns. Market dynamics may also be impacted by legal ramifications of unfavorable incidents or issues.

Global Endobronchial Tubes Market Segmentation Analysis

The Global Endobronchial Tubes Market is Segmented on the basis of Product, Application, And Geography.

Endobronchial Tubes Market, By Product

• Single Use/Disposable
• Reusable

Based on Product, The market is segmented into Single Use/Disposable and Reusable. The Single Use/Disposable segment holds the big market share. This is because it will help in the prevention of infection among various humans and these pipes are biodegradable also and also do not affect the environment too.

Endobronchial Tubes Market, By Application

• Hospitals
• Ambulatory Surgical Clinics
• Specialty Clinics

Based on Application, The market is segmented into Hospitals, Ambulatory Surgical Clinics, and Specialty Clinics. The hospital segment accounted for the largest share of market revenue, and this is expected to continue throughout the forecast period. The global Endobronchial Tubes Market is expected to grow due to advancements in coated endotracheal tubes, an increase in the incidence of ventilator-associated pneumonia, increased awareness of technologically advanced endotracheal tubes, and developments in the fields of nano-bio application and drug design.

Endobronchial Tubes Market, By Geography

• North America
• Europe
• Asia Pacific
• Rest of the world
• On the basis of Geography, The Endobronchial Tubes Market is classified into North America, Europe, Asia Pacific, and the Rest of the world. North America led the market, accounting for the largest share, and this trend is expected to continue throughout the forecast period. The rise in demand for coated endotracheal tubes in such disorders is a significant reason that contributes to the growth of the Endobronchial Tubes Market. This is related to the growing cases of pulmonary ailments, pneumonia, cancer, and other conditions.

Key Players

• The "Global Endobronchial Tubes Market" study report will provide a valuable insight with an emphasis on the global market including some of the major players such as
• Sonoma Pharmaceuticals Inc., Teleflex Incorporated, Venner Medical GmbH, Enox Biopharma Inc., Hospiteknik Healthcare, Innovative Surface Technologies, Inc., Bactiguard Holding AB, C. R. Bard, Inc., N8 Medical, LLC, and Sharklet Technologies, Inc.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with its product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL ENDOBRONCHIAL TUBES MARKET

• 1.1 Overview of the Market
• 1.2 Scope of Report
• 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

• 3.1 Data Mining
• 3.2 Validation
• 3.3 Primary Interviews
• 3.4 List of Data Sources

4 GLOBAL ENDOBRONCHIAL TUBES MARKET OUTLOOK

• 4.1 Overview
• 4.2 Market Dynamics
  • 4.2.1 Drivers
  • 4.2.2 Restraints
  • 4.2.3 Opportunities
• 4.3 Porters Five Force Model
• 4.4 Value Chain Analysis

5 GLOBAL ENDOBRONCHIAL TUBES MARKET, BY PRODUCT

• 5.1 Overview
• 5.2 Single Use/Disposable
• 5.3 Reusable

6 GLOBAL ENDOBRONCHIAL TUBES MARKET, BY APPLICATION

• 6.1 Overview
• 6.2 Hospitals
• 6.3 Ambulatory Surgical Clinics
• 6.4 Specialty Clinics

7 GLOBAL ENDOBRONCHIAL TUBES MARKET, BY GEOGRAPHY

• 7.1 Overview
• 7.2 North America
  • 7.2.1 U.S.
  • 7.2.2 Canada
  • 7.2.3 Mexico
• 7.3 Europe
  • 7.3.1 Germany
  • 7.3.2 U.K.
  • 7.3.3 France
  • 7.3.4 Rest of Europe
• 7.4 Asia Pacific
  • 7.4.1 China
  • 7.4.2 Japan
  • 7.4.3 India
  • 7.4.4 Rest of Asia Pacific
• 7.5 Rest of the World
  • 7.5.1 Latin America
  • 7.5.2 Middle East & Africa

8 GLOBAL ENDOBRONCHIAL TUBES MARKET COMPETITIVE LANDSCAPE

• 8.1 Overview
• 8.2 Company Market Ranking
• 8.3 Key Development Strategies

9 COMPANY PROFILES

• 9.1 Sonoma Pharmaceuticals Inc
  • 9.1.1 Overview
  • 9.1.2 Financial Performance
  • 9.1.3 Product Outlook
  • 9.1.4 Key Developments
• 9.2 Teleflex Incorporated
  • 9.2.1 Overview
  • 9.2.2 Financial Performance
  • 9.2.3 Product Outlook
  • 9.2.4 Key Developments
• 9.3 Venner Medical GmbH
  • 9.3.1 Overview
  • 9.3.2 Financial Performance
  • 9.3.3 Product Outlook
  • 9.3.4 Key Developments
• 9.4 Enox Biopharma Inc
  • 9.4.1 Overview
  • 9.4.2 Financial Performance
  • 9.4.3 Product Outlook
  • 9.4.4 Key Developments
• 9.5 Hospiteknik Healthcare
  • 9.5.1 Overview
  • 9.5.2 Financial Performance
  • 9.5.3 Product Outlook
  • 9.5.4 Key Developments
• 9.6 Innovative Surface Technologies, Inc
  • 9.6.1 Overview
  • 9.6.2 Financial Performance
  • 9.6.3 Product Outlook
  • 9.6.4 Key Developments
• 9.7 Bactiguard Holding AB
  • 9.7.1 Overview
  • 9.7.2 Financial Performance
  • 9.7.3 Product Outlook
  • 9.7.4 Key Developments
• 9.8 C. R. Bard, Inc
  • 9.8.1 Overview
  • 9.8.2 Financial Performance
  • 9.8.3 Product Outlook
  • 9.8.4 Key Developments
• 9.9 N8 Medical, LLC
  • 9.9.1 Overview
  • 9.9.2 Financial Performance
  • 9.9.3 Product Outlook
  • 9.9.4 Key Developments
• 9.10 Sharklet Technologies, Inc
  • 9.10.1 Overview
  • 9.10.2 Financial Performance
  • 9.10.3 Product Outlook
  • 9.10.4 Key Developments

10 Appendix

• 10.1 Related Research